Jaehoon Lee | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Jaehoon Lee
Affiliation Clinical Medicine; vascular and endovascular surgery
Country South Korea
Google Scholar View Profile
Documents 25
Citations 155
h-index 8
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-0906-5236

Jaehoon Lee is a South Korean clinician-researcher working in vascular and endovascular surgery within clinical medicine. His documented publications address peripheral arterial disease, endovascular aneurysm repair, vascular access, arterial reconstruction, and device-based interventions. His work combines clinical outcomes, procedural evaluation, imaging, and statistical analysis to examine practical vascular treatment strategies. [1]

Abstract

Jaehoon Lee is a South Korean clinical medicine researcher whose documented work focuses on vascular and endovascular surgery. His publications address endovascular aneurysm repair, peripheral arterial disease, femorofemoral bypass, arteriovenous access thrombosis, and emerging procedural approaches. The research emphasizes anatomical assessment, graft performance, procedural feasibility, postoperative complications, and clinical outcomes. His studies include retrospective analyses, case-based investigations, and multicenter prospective research, reflecting an applied approach to vascular care. The publication record demonstrates sustained interest in improving revascularization strategies, evaluating vascular devices, and identifying factors associated with treatment outcomes. These contributions support consideration for an Innovative Research Award in Clinical Medicine.

Keywords

Vascular surgery; endovascular surgery; peripheral arterial disease; endovascular aneurysm repair; abdominal aortic aneurysm; femorofemoral bypass; saphenous vein graft; polytetrafluoroethylene; vascular access; arteriovenous fistula; thrombosis; rotational atherectomy; infrainguinal arterial disease; revascularization; graft patency; iliac branch device; arterial anatomy; vascular devices; clinical outcomes; postoperative complications; predictive modeling; machine learning; atherosclerosis; clinical medicine.

Introduction

Jaehoon Lee is a South Korean clinician-researcher working in vascular and endovascular surgery within clinical medicine. His documented publications address peripheral arterial disease, endovascular aneurysm repair, vascular access, arterial reconstruction, and device-based interventions. His work combines clinical outcomes, procedural evaluation, imaging, and statistical analysis to examine practical vascular treatment strategies. [1]

Research Profile

Jaehoon Lee’s research profile centers on vascular and endovascular surgery, with publications involving abdominal aortic aneurysm repair, femorofemoral bypass, arteriovenous access, and infrainguinal arterial disease. His documented work reflects clinically oriented investigation, retrospective and multicenter study designs, procedural assessment, and evaluation of anatomical or treatment factors affecting outcomes today broadly. [2]

Research Contributions

Jaehoon Lee has contributed to clinical vascular research through studies evaluating endovascular aneurysm repair, graft selection, vascular access thrombosis, and contemporary peripheral interventions. His publications examine technical feasibility, anatomical change, graft patency, postoperative complications, and longer-term clinical outcomes, providing evidence relevant to decision-making in vascular surgery practice and patient care. [3]

Publications

Jaehoon Lee’s documented publication record includes research on changes following endovascular aneurysm repair, custom-made iliac branch devices, femorofemoral bypass graft selection, postoperative thrombosis of arteriovenous access, and predictive modeling of arteriovenous fistula occlusion. Recent multicenter research also examines rotational atherectomy with antirestenotic therapy for infrainguinal arterial disease. [1] [2]

Research Impact

Jaehoon Lee’s research has clinical relevance because vascular diseases require durable revascularization, careful anatomical assessment, and management of procedure-related complications. His studies address these needs through outcome-oriented analyses of bypass grafts, endovascular repair, dialysis access, and peripheral arterial interventions, supporting evidence-based refinement of vascular surgical and endovascular practice clinically directly. [3] [4]

Award Suitability

Jaehoon Lee demonstrates a research portfolio aligned with Innovative Research Award consideration in Clinical Medicine, particularly vascular and endovascular surgery. His documented studies investigate procedural strategies, device applications, graft alternatives, predictive modeling, and multicenter peripheral arterial treatment. The portfolio shows sustained clinical investigation and practical relevance to contemporary vascular care.[5]

Conclusion

Jaehoon Lee’s documented research demonstrates a consistent clinical focus on vascular and endovascular medicine, spanning aneurysm repair, peripheral arterial disease, bypass surgery, vascular access, and procedural innovation. The available publication record supports recognition of a clinically relevant research program that connects technical investigation with patient-centered outcomes and evolving vascular practice.[4]

References

  1. Lee JH, Park KH, Kwak SG. Changes in Neck Angle, Neck Length, Maximum Diameter, Maximum Area and Thrombus after Endovascular Aneurysm Repair. Vascular Specialist International. https://doi.org/10.5758/vsi.190054
  2. Park YE, Lee JH, Yun WS, Park KH. Surgeon custom-made iliac branch device to salvage hypogastric artery during endovascular aneurysm repair. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2014.29.12.1678
  3. Kwon G, Park KH, Kwak SG, Lee JH. The Results of Femorofemoral Bypass Using a Saphenous Vein Graft as an Alternative to PTFE Grafts. Vascular Specialist International. https://doi.org/10.5758/vsi.220060
  4. Kim J, Park K, Cho Y, Lee J. The Effects of Vasodilation Induced by Brachial Plexus Block on the Development of Postoperative Thrombosis of the Arteriovenous Access in Patients with End-Stage Renal Disease: A Retrospective Study. International Journal of Environmental Research and Public Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC9690458/
  5. Lee JH, Kwak SG. Development of a Machine Learning-Based Predictive Model for Arteriovenous Fistula Occlusion After Surgery: A Retrospective Cohort Study from 2015 to 2025. Medicina. https://doi.org/10.3390/medicina61122150

Bernd Fink | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Bernd Fink
Affiliation Orthopaedic Clinic Markgröningen
Country Germany
Scopus ID 22943409800
Documents 176
Citations 3,339
h-index 29
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-7485-3941
Bernd Fink – Orthopaedic Clinic Markgröningen, Germany

Bernd Fink is a German orthopaedic surgeon and clinical researcher whose scholarly work primarily focuses on hip and knee arthroplasty, implant fixation, revision surgery, prosthetic joint infection, and long-term orthopedic outcomes. His scientific publications have contributed to improving evidence-based clinical practice through investigations into implant performance, surgical techniques, and patient-centered treatment strategies. His academic profile reflects sustained engagement with musculoskeletal research and international collaboration within clinical medicine.[1]

Abstract

Bernd Fink has established an internationally recognized academic profile through clinical investigations involving hip arthroplasty, knee replacement, implant fixation, revision procedures, prosthetic joint infection, biomaterials, and orthopedic outcomes. His publications emphasize evidence-based surgical decision-making, implant longevity, patient safety, and postoperative functional recovery. By integrating clinical observations with long-term follow-up studies, his research supports improvements in orthopedic practice and healthcare quality. His contributions continue influencing musculoskeletal surgery through scientifically validated findings that benefit clinicians, researchers, and patients while strengthening international orthopedic literature and advancing modern clinical medicine through collaborative multidisciplinary research worldwide.[2]

Keywords

Hip Arthroplasty, Knee Arthroplasty, Revision Arthroplasty, Prosthetic Joint Infection, Cementless Implant, Implant Fixation, Acetabular Cup, Femoral Stem, Orthopaedic Surgery, Clinical Outcomes, Total Hip Replacement, Joint Reconstruction.

Introduction

Bernd Fink investigates orthopedic surgery through clinically relevant research addressing joint replacement, revision strategies, implant fixation, infection prevention, and long-term patient outcomes. His scholarly publications integrate practical surgical experience with scientific evaluation, supporting evidence-based improvements in musculoskeletal healthcare while strengthening contemporary orthopedic knowledge through internationally recognized clinical investigations.[1]

Research Profile

Bernd Fink maintains an active research profile centered on hip arthroplasty, knee replacement surgery, prosthetic joint infection, implant survival, revision procedures, and orthopedic biomechanics. His publications demonstrate sustained collaboration with international researchers while contributing valuable clinical evidence supporting safer surgical interventions and improved patient rehabilitation across orthopedic practice.[2]

Research Contributions

Bernd Fink contributes significantly by evaluating implant performance, optimizing revision arthroplasty techniques, investigating prosthetic infections, and improving postoperative recovery through evidence-based orthopedic studies. His findings assist clinicians in selecting effective surgical approaches while promoting durable implant performance and enhanced quality of patient-centered musculoskeletal healthcare internationally.[3]

Publications

Bernd Fink has published extensively on hip arthroplasty, knee replacement, prosthetic joint infection, implant fixation, revision surgery, and long-term orthopedic outcomes. His scholarly articles emphasize evidence-based surgical practice, implant longevity, patient recovery, and clinical decision-making, providing valuable scientific knowledge that supports continuous advancements in modern orthopedic medicine worldwide.[3]

Research Impact

Bernd Fink’s research provides clinically meaningful evidence supporting orthopedic surgeons managing complex arthroplasty cases. His publications strengthen understanding of implant longevity, revision surgery, prosthetic infection prevention, and postoperative rehabilitation. These scholarly contributions continue supporting healthcare professionals seeking reliable evidence for improving orthopedic surgical quality and patient outcomes.[4]

Award Suitability

Bernd Fink demonstrates qualities consistent with recognition through the Innovative Research Award because his sustained orthopedic investigations have strengthened evidence-based clinical medicine. His scholarly contributions, publication record, international visibility, and commitment to improving arthroplasty outcomes collectively reflect meaningful scientific achievement deserving academic recognition within contemporary health sciences.[4]

Conclusion

Bernd Fink continues contributing valuable scientific knowledge through orthopedic clinical research emphasizing implant performance, revision surgery, infection management, and patient outcomes. His publications support evidence-based healthcare while promoting continuous improvements in musculoskeletal medicine. His academic achievements illustrate a sustained commitment to advancing clinical medicine through rigorous scientific investigation.[2]

References

  1. Scopus Author Profile. Bernd Fink.
    https://www.scopus.com/authid/detail.uri?authorId=22943409800
  2. ORCID. Bernd Fink Research Profile.
    https://orcid.org/0000-0002-7485-3941
  3. Fink, B., & Tetsworth, K. D. (2017). Antibiotic elution from cement spacers and its influencing factors.
    https://doi.org/10.3390/antibiotics14070705
  4. ResearchGate Profile.
    https://www.researchgate.net/profile/Bernd-Fink-3
  5. Health Scientists Awards.
    https://healthscientists.org/

Sarfaraz Niazi | Clinical Medicine | Lifetime Achievement Award

Published on by Health Scientists

Lifetime Achievement Award

Sarfaraz Niazi
Affiliation Washington State University
Country United States
Scopus ID 7004749563
Documents 156
Citations
2,572
h-index 26
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-0513-0336

Sarfaraz Niazi
Washington State University, United States

Sarfaraz Niazi is an internationally recognized pharmaceutical scientist whose scholarly work has significantly influenced pharmaceutical formulation science, manufacturing technologies, dosage form development, drug delivery systems, regulatory sciences, and pharmaceutical product commercialization. His publications, technical handbooks, and scientific contributions have been extensively utilized by academic researchers, pharmaceutical industries, regulatory professionals, and healthcare innovators worldwide. His sustained research productivity, educational publications, and practical innovations demonstrate long-term contributions to clinical medicine and pharmaceutical sciences deserving scholarly recognition.[1]

Abstract

Sarfaraz Niazi has established a distinguished academic career through influential research, authoritative pharmaceutical reference books, and practical innovations supporting drug formulation, pharmaceutical manufacturing, analytical development, quality assurance, and commercialization. His scholarly publications have contributed to improving pharmaceutical education, industrial manufacturing practices, regulatory understanding, and formulation science across diverse healthcare applications. The breadth of his scientific output, sustained international citation record, and educational influence demonstrate enduring contributions to clinical medicine and pharmaceutical sciences while supporting innovation, professional training, and evidence-based pharmaceutical development worldwide.[2]

Keywords

Pharmaceutical formulation, Drug delivery, Pharmaceutical manufacturing, Dosage forms, Preformulation, Drug development, Regulatory science, Clinical medicine, Pharmaceutical technology, Quality assurance, Drug discovery, Formulation development.

Introduction

Sarfaraz Niazi has contributed extensively to pharmaceutical sciences through multidisciplinary research integrating formulation development, manufacturing technologies, analytical methodologies, and industrial pharmaceutical practice. His scientific publications and reference books continue supporting researchers, educators, pharmaceutical manufacturers, and healthcare professionals seeking evidence-based approaches for modern pharmaceutical product development and commercialization.[3]

Research Profile

Sarfaraz Niazi has maintained an internationally recognized scholarly profile characterized by influential publications, comprehensive pharmaceutical textbooks, industrial expertise, and sustained academic engagement. His research spans pharmaceutical manufacturing, formulation optimization, regulatory sciences, dosage form technologies, and translational pharmaceutical innovation supporting healthcare advancement through scientific excellence.[1]

Research Contributions

Sarfaraz Niazi has advanced pharmaceutical sciences by developing authoritative resources addressing formulation strategies, manufacturing processes, quality systems, and commercialization pathways. His publications bridge academic knowledge with industrial implementation, strengthening pharmaceutical education while facilitating innovation in drug development, product quality, and therapeutic manufacturing technologies worldwide.[4]

Publications

Sarfaraz Niazi has authored influential books and peer-reviewed publications covering pharmaceutical preformulation, liquid dosage manufacturing, computer-aided drug discovery, pharmaceutical technologies, and industrial formulation sciences. These scholarly resources remain widely referenced within universities, pharmaceutical industries, regulatory organizations, and professional research environments internationally.[5]

Research Impact

Sarfaraz Niazi has generated enduring academic and industrial influence through publications supporting pharmaceutical innovation, formulation optimization, manufacturing quality, and educational advancement. His scholarly contributions continue assisting researchers and healthcare industries in developing effective pharmaceutical products while strengthening evidence-based pharmaceutical sciences internationally.[2]

Award Suitability

Sarfaraz Niazi demonstrates sustained scholarly excellence through influential research publications, internationally recognized pharmaceutical references, educational leadership, and practical industrial innovation. These long-term scientific achievements, combined with substantial global academic influence, strongly align with the objectives and recognition standards associated with the Lifetime Achievement Award.[1]

Conclusion

Sarfaraz Niazi has built an internationally respected scientific legacy through pharmaceutical research, industrial innovation, educational scholarship, and authoritative publications. His lasting influence across pharmaceutical sciences, clinical medicine, formulation technology, and healthcare education reflects the sustained excellence expected from recipients of distinguished international scientific recognition.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Sarfaraz Niazi, Author ID 7004749563. Scopus.
    https://www.scopus.com/pages/authors/7004749563
  2. ORCID. (n.d.). Sarfaraz Niazi ORCID Record.
    https://orcid.org/0000-0002-0513-0336
  3. Google Scholar. (n.d.). Scholar Profile: Sarfaraz Niazi.
    https://scholar.google.com/citations?user=O2dgTYIAAAAJ&hl=en&oi=ao
  4. ResearchGate. (n.d.). Sarfaraz Niazi Research Profile.
    https://www.researchgate.net/profile/Sarfaraz-Niazi-3
  5. Niazi, S. K., & Mariam, Z. (2024). Computer-aided Drug Design and Drug Discovery: A Prospective Analysis. Pharmaceuticals.
    https://doi.org/10.3390/ph17010022

Konstantin Konstantinov | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Konstantin Konstantinov
Researcher Konstantin Konstantinov
Affiliation University of New Mexico
Country United States
Scopus ID 55808069944
Documents 38
Citations
2,384
h-index 17
Subject Area Clinical Medicine
Event Health Scientists Awards

Konstantin Konstantinov
University of New Mexico

Konstantin Konstantinov, affiliated with the University of New Mexico, is a researcher in Clinical Medicine whose scholarly work contributes to advancing evidence-based biomedical research. His publications indexed in Scopus demonstrate sustained engagement with clinically relevant investigations, interdisciplinary collaboration, and scientific dissemination. This recognition article summarizes his research profile, scholarly contributions, publication themes, research impact, and suitability for the Health Scientists Awards, based on publicly available academic records and recognized scholarly databases.[1]

Abstract

Konstantin Konstantinov has established an academic profile within Clinical Medicine through scholarly publications emphasizing translational biomedical research, disease mechanisms, diagnostic innovation, clinical applications, and collaborative investigation. His work reflects sustained participation in internationally indexed research while contributing to evidence-based healthcare knowledge. Publications demonstrate methodological rigor, scientific relevance, and interdisciplinary cooperation across medical sciences. Indexed visibility through Scopus and ORCID supports transparent scholarly communication and research accessibility. Collectively, these achievements indicate meaningful engagement with contemporary clinical research and provide a credible foundation for recognition through international academic awards dedicated to advancing health sciences and biomedical innovation.[1][2]

Keywords

Clinical Medicine, Biomedical Research, Translational Medicine, Disease Mechanisms, Biomarkers, Immunology, Molecular Medicine, Diagnostics, Therapeutics, Patient Care, Precision Medicine, Clinical Investigation, Medical Innovation, Healthcare Research, Evidence-Based Medicine.

Introduction

Konstantin Konstantinov conducts research emphasizing clinically relevant biomedical investigations that integrate laboratory findings with healthcare applications. His scholarly activities contribute to understanding disease processes, improving diagnostic strategies, and strengthening translational medicine. Indexed publications demonstrate consistent scientific engagement while supporting evidence-driven clinical practice across multidisciplinary healthcare environments.[1]

Research Profile

Konstantin Konstantinov maintains a recognized research profile through Scopus and ORCID, reflecting internationally indexed scholarly contributions. His affiliation with the University of New Mexico supports collaborative medical research, interdisciplinary partnerships, and dissemination of findings within respected scientific journals addressing clinical medicine and biomedical innovation.[2]

Research Contributions

Konstantin Konstantinov contributes to biomedical knowledge through investigations addressing clinical challenges, disease biology, and translational healthcare solutions. His research emphasizes scientific reliability, collaborative methodologies, and practical medical relevance, helping strengthen understanding of therapeutic development while supporting continued advancement of evidence-based clinical medicine internationally.[3]

Publications

Konstantin Konstantinov has authored and co-authored peer-reviewed publications indexed within Scopus, reflecting sustained participation in internationally recognized biomedical literature. His publication portfolio demonstrates scientific consistency, collaborative authorship, and continuing contributions to clinical medicine through research addressing contemporary healthcare questions and translational scientific applications.[1]

Research Impact

Konstantin Konstantinov demonstrates measurable scholarly visibility through internationally indexed publications, citation tracking, and persistent researcher identifiers. His scientific contributions encourage collaboration, knowledge dissemination, and continuing academic influence within clinical medicine while supporting reproducible research standards and responsible advancement of healthcare-related scientific investigation.[2]

Award Suitability

Konstantin Konstantinov demonstrates characteristics aligned with the objectives of the Health Scientists Awards through sustained scholarly productivity, internationally indexed research, interdisciplinary collaboration, and clinically relevant scientific contributions. His academic profile supports consideration for recognition based upon documented research quality, visibility, and professional scientific engagement.[4]

Conclusion

Konstantin Konstantinov represents an active clinical medicine researcher whose internationally indexed publications, institutional affiliation, and commitment to evidence-based biomedical investigation demonstrate meaningful scientific engagement. His documented academic profile provides an appropriate basis for professional recognition within international research award programs supporting healthcare innovation and scientific excellence.[1]

External Links

References

    1. Elsevier. (n.d.). Scopus Author Details: Konstantin Konstantinov, Author ID 55808069944. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=55808069944
    2. Konstantinov, K. N., Roldan, C. A., & Konstantinov, N. K. (n.d.). Sclerodactyly, tongue telangiectasias, premature severe aortic stenosis, and RNA polymerase III autoantibodies in a patient with syncope.
      https://pubmed.ncbi.nlm.nih.gov/37979901/

    3. Kumar, V., de Saint-Aubain, C. J., & Konstantinov, K. N. (n.d.). A diagnostic odyssey: Mevalonate kinase deficiency revealed by genetic testing in adulthood.

      https://doi.org/10.3390/genes17040439

    4. Health Scientists Awards. (n.d.). Official Awards Website.
      https://healthscientists.org/

Pao-Chu Chen | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Best Researcher Award

Pao-Chu Chen — Hualien Tzu Chi Hospital
Academic Profile
Researcher Pao-Chu Chen
Affiliation Hualien Tzu Chi Hospital
Country Taiwan
Scopus ID 37081956700
Documents 30
Citations 307
h-index 8
Subject Area Clinical Medicine
Event Health Scientists Awards
ResearchGate Profile Link

Pao-Chu Chen is affiliated with Hualien Tzu Chi Hospital in Taiwan and has contributed to clinical medicine research through indexed scientific publications and interdisciplinary healthcare studies. The academic profile demonstrates measurable citation impact and participation in scientific communication systems associated with international biomedical research visibility.[1]

Abstract

This article summarizes the academic profile and scientific contributions of Pao-Chu Chen from Hualien Tzu Chi Hospital, Taiwan. The researcher has contributed to clinical medicine through indexed publications, interdisciplinary healthcare research, and scholarly communication activities. Citation indicators and publication metrics demonstrate measurable academic visibility within international biomedical databases. The profile reflects participation in scientific dissemination, healthcare investigation, and research collaboration associated with clinical medicine and public health advancement. Recognition within the Health Scientists Awards framework highlights scholarly engagement, publication quality, and contribution to evidence-based healthcare research within contemporary academic and clinical environments.[1]

Keywords

  • Clinical Medicine
  • Biomedical Research
  • Health Sciences
  • Healthcare Studies
  • Scopus Author Profile
  • Health Scientists Awards

Introduction

Clinical medicine research contributes to evidence-based healthcare practices, disease management, and interdisciplinary scientific advancement. Researchers engaged in this field support medical knowledge dissemination through peer-reviewed publications, healthcare investigations, and collaborative scientific communication systems within international academic and clinical research environments.[2]

Research Profile

Pao-Chu Chen maintains an academic profile associated with Hualien Tzu Chi Hospital and indexed scientific publications in clinical medicine. Bibliometric indicators demonstrate research visibility through citation activity, scholarly dissemination, and participation in international scientific databases supporting healthcare-related academic communication.[1]

Research Contributions

The researcher has contributed to clinical medicine through healthcare investigations, biomedical publication activities, and scientific collaboration. Research dissemination through indexed journals supports the exchange of validated medical knowledge and strengthens interdisciplinary communication within international healthcare and biomedical research communities.[3]

Publications

The publication record associated with Pao-Chu Chen includes indexed scientific articles contributing to clinical medicine and healthcare research. Peer-reviewed publications support citation visibility, academic dissemination, and integration into international bibliographic databases used for scholarly communication and biomedical knowledge distribution.[1]

Research Impact

Research impact is reflected through publication indexing, citation metrics, and participation in scientific communication systems. The researcher’s academic profile demonstrates measurable scholarly visibility and contribution to healthcare-related scientific literature within internationally recognized biomedical and clinical research databases.[1]

Award Suitability

The academic profile of Pao-Chu Chen aligns with recognition criteria associated with scientific publication activity, citation visibility, and healthcare research contribution. Participation in indexed scholarly communication systems demonstrates engagement with biomedical dissemination practices supporting international academic and clinical research advancement.[4]

Conclusion

Pao-Chu Chen demonstrates sustained involvement in clinical medicine research through indexed publications, citation visibility, and scientific dissemination activities. The academic profile reflects interdisciplinary healthcare engagement and contribution to biomedical scholarship within international research environments supporting evidence-based healthcare communication and scientific advancement.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Pao-Chu Chen, Author ID 37081956700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=37081956700
  2. Subramani, K., Su, C.-C., Wang, J.-H., Huang, H.-S., Hsu, C.-S., Chen, P.-C., & Chu, T.-Y. (2025). Tubal ligation exacerbates ovulation-driven TP53 mutagenesis and p53 signatures by depleting protective menstrual hemoglobin. The Journal of Pathology.
    https://pathsocjournals.onlinelibrary.wiley.com/doi/abs/10.1002/path.70064
  3. Chu, T., Chen, Pao-Chu, Khine, A. A., et al. (2025). Ovulation releases G-CSF to induce peritoneal neutrophil influx and netosis, facilitating peritoneal seeding of high-grade serous carcinoma. Neoplasia.
    https://pubmed.ncbi.nlm.nih.gov/41046768/
  4. Health Scientists Awards. (n.d.). Academic recognition and scientific excellence framework.
    Health Scientists Awards

Eleftherios Papaeleftheriou | Clinical Medicine | Top Clinical Research Award

Published on by Health Scientists

Top Clinical Research Award

Eleftherios Papaeleftheriou
St. Mary’s Hospital Mülheim an der Ruhr, Germany

Eleftherios Papaeleftheriou
Researcher Eleftherios Papaeleftheriou
Affiliation St. Mary’s Hospital Mülheim an der Ruhr
Country Germany
Scopus ID 53881624200
Documents 2
Citations 7
h-index 1
Subject Area Clinical Medicine
Event Health Scientists Awards
Scopus Profile View Profile

The Top Clinical Research Award recognizes the scholarly and clinical research contributions of Eleftherios Papaeleftheriou associated with St. Mary’s Hospital Mülheim an der Ruhr in Germany. The recognition reflects engagement in Clinical Medicine research, scientific communication, and internationally indexed academic dissemination through peer-reviewed publication activity.[1] The award framework acknowledges measurable scholarly participation within clinical and healthcare-oriented research environments supported by internationally recognized academic indexing systems.[2] Additional scholarly infrastructure and citation indexing resources further support international accessibility and publication discoverability.[3]

Abstract

Eleftherios Papaeleftheriou is associated with scholarly activities in Clinical Medicine and healthcare-related research dissemination. Indexed academic contributions reflect participation in peer-reviewed publication systems, citation-based evaluation, and scientific communication relevant to clinical and medical investigation.[1] Research visibility supported through international academic platforms contributes to broader engagement within healthcare and clinical research communities.[3]

Keywords

  • Clinical Medicine
  • Medical Research
  • Scientific Dissemination
  • Clinical Investigation
  • Healthcare Innovation
  • Academic Publications
  • Indexed Research

Introduction

Academic recognition programs in healthcare and biomedical sciences acknowledge scholarly contribution and international scientific communication. The Health Scientists Awards Top Clinical Research Award recognizes researchers engaged in clinical investigation and indexed dissemination.[2] Eleftherios Papaeleftheriou demonstrates scholarly involvement in Clinical Medicine through indexed publications and citation-based evaluation, contributing to academic visibility and engagement within broader medical research communities.[1]

Research Profile

Eleftherios Papaeleftheriou is affiliated with St. Mary’s Hospital Mülheim an der Ruhr in Germany and maintains a scholarly profile indexed through Scopus academic databases.[1] The research profile includes two indexed documents, seven citations, and an h-index value of one, demonstrating participation in scholarly communication and clinical research dissemination. The researcher’s academic activities are associated with Clinical Medicine and healthcare-oriented scientific inquiry, supporting knowledge dissemination within peer-reviewed and internationally accessible research environments.[3]

Research Contributions

The scholarly activities associated with Eleftherios Papaeleftheriou contribute to medical and healthcare-oriented academic communication through indexed publication and citation-based dissemination systems.[1]

  • Participation in clinical and healthcare-related academic research.
  • Contribution to peer-reviewed scientific publication systems.
  • Support for internationally indexed research dissemination.
  • Engagement in citation-based scholarly communication activities.

Publications

Indexed publications associated with Eleftherios Papaeleftheriou contribute to academic visibility and accessibility within international scientific databases. Citation metrics and indexed documentation support evaluation of scholarly dissemination and clinical research engagement.[1]

  1. Peer-reviewed publications associated with Clinical Medicine.
  2. Scientific dissemination through internationally indexed academic databases.
  3. Citation-based contribution to healthcare-related scholarly communication.

Research Impact

Research impact within Clinical Medicine is commonly evaluated through publication visibility, citation activity, and participation in internationally recognized scientific dissemination systems. The indexed academic profile associated with Eleftherios Papaeleftheriou reflects measurable scholarly engagement within healthcare-oriented research environments.[1] Recognition through international academic award frameworks may additionally support interdisciplinary networking, collaborative healthcare investigation, and broader scientific communication opportunities.[2]

Award Suitability

The academic and clinical research profile of Eleftherios Papaeleftheriou reflects characteristics associated with scholarly recognition programs, including indexed publication activity, citation-based visibility, and participation in international scientific dissemination systems.[1] The researcher’s engagement within Clinical Medicine contributes to healthcare-related academic communication and supports continued participation within global scientific and medical research initiatives.[3]

Conclusion

Eleftherios Papaeleftheriou demonstrates scholarly participation within Clinical Medicine through indexed publication activity, scientific dissemination, and engagement in internationally accessible healthcare research systems.[1] Citation indicators and publication visibility collectively support recognition within academic and clinical research communities.[3] The Top Clinical Research Award under the Health Scientists Awards framework represents acknowledgment of scholarly contribution, healthcare-oriented scientific engagement, and participation in international research dissemination initiatives.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Eleftherios Papaeleftheriou, Author ID 53881624200. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=53881624200
  2. Health Scientists Awards. (n.d.). International academic recognition and healthcare research award framework.

    https://healthscientists.org/
  3. Sowislok, A., Gruber, G., Kaschani, F., Kaiser, M., Papaeleftheriou, E., & Jäger, M. (2025). Intraoperative Biologization of β-TCP and PCL-TCP by Autologous Proteins. PubMed.

    https://pubmed.ncbi.nlm.nih.gov/41003411/

Nabil Alageli | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Assoc. Prof. Dr. Nabil Alageli | Clinical Medicine | Research Excellence Award

Consultant Orthopaedic Surgeon | Tripoli University Hospital | Libya

Prof. Nabil A. Alageli is a distinguished consultant orthopaedic and spine surgeon and an associate professor of surgery whose career reflects longstanding commitment to clinical excellence, academic leadership, and national health-system development. His expertise spans complex trauma, spinal injuries, degenerative spine disorders, arthroscopic procedures, and joint reconstruction, complemented by substantial experience in managing large tertiary hospitals and advancing medical training programs.His contributions to hospital governance, health-system reform initiatives, and professional societies underscore his broader societal impact, reflecting a career dedicated not only to surgical practice but also to advancing healthcare quality, institutional capacity, and community service. He has 25 citations from 3 documents with an h-index of 2.

Citation Metrics (Scopus)

25

20

15

10

5

0

Citations
25

Documents
3

h-index
2

                       🟦 Citations             🟥 Documents          🟩 h-index

View Google Scholar Profile
 View Scopus Profile
 View Orcid Profile

Featured Publications

Zelimkhan Berikkhanov | Clinical Medicine | Young Researcher Award

Published on by Health Scientists

Mr. Zelimkhan Berikkhanov | Clinical Medicine | Young Researcher Award

Assistant Professor | I.M. Sechenov First Moscow State Medical University | Russia

Dr. Zelimkhan Berikkhanov is a clinician-scientist whose work spans thoracic surgery, pulmonology, infectious diseases, oncology, and public health, with a strong emphasis on developing evidence-based approaches to complex respiratory and surgical disorders. His professional career integrates academic leadership as an assistant professor and methodologist with active clinical responsibilities at the National Medical Research Center for Pulmonology and Sechenov University, where he contributes to advanced surgical care, methodological development, and multidisciplinary education. His research portfolio reflects a diverse and impactful scholarly trajectory, encompassing peer-reviewed studies on tracheal reconstruction, thoracic oncology, diaphragmatic trauma, critical respiratory conditions, chronic obstructive pulmonary disease, COVID-associated pneumonia, nanomaterials in gastrointestinal pathology, digital tools in chronic disease management, and telemedicine in pulmonology. He has collaborated extensively with leading national and international experts, contributing to multi-center investigations, clinical guidelines, and translational research aimed at improving diagnostic accuracy, postoperative outcomes, and respiratory care pathways. His scientific productivity is demonstrated through a broad range of publications across high-quality journals, addressing both fundamental mechanisms and applied clinical innovations. His work on COVID-19 significantly advanced understanding of silent hypoxemia, cavitary lung disease, vibroacoustic therapy, and pharmacologic strategies, while his contributions to thoracic surgery strengthened evidence on complex tracheal and bronchial interventions. His participation in research on artificial intelligence for mortality prediction, biomarkers for pulmonary hypertension, metabolic instability in malignancies, and advanced imaging of the lymphatic system underscores his commitment to cross-disciplinary innovation. Through active collaboration, methodological leadership, and involvement in forward-looking clinical studies, Dr. Berikkhanov has helped shape modern approaches to respiratory medicine and thoracic surgery, generating insights that support better patient outcomes and inform national strategies in pulmonary care. His work continues to influence clinical practice, strengthen scientific networks, and enhance healthcare delivery through integrated, technology-supported, and patient-centered frameworks. He has 62 citations from 27 documents with an h-index of 4.

Profiles:  Scopus | ORCID

Featured Publications

1. Sukhanova, M. A., Muraviev, S. Y., Tarabrin, E. A., Shestakov, A. L., Berikkhanov, Z. G. M., Tarasova, I. A., Razumovsky, V. S., Markov, I. A., & Fabrika, A. P. (2025). The role of “metabolic instability” as a new risk criterion in the pathogenesis of endometrial cancer. Cancers.

2. Nagatkina, O. V., Proshkina, A. A., Makarova, N. M., Sokolova, E. S., Merzhoeva, Z. M., Nikitina, L. Y., Nuralieva, G. S., Berikchanov, Z. G., Ainetdinov, R. M., & Avdeev, S. N. (2025). Digital technologies for outpatient management of patients with chronic obstructive pulmonary disease: Opportunities to reduce the burden of the disease. Russian Journal of Preventive Medicine.

3. Ma, T., Berikkhanov, Z. G., Timashev, P. S., Khristidis, Y. I., Ivanova, M. Y., Ershov, B. P., Liu, T., & Tarabrin, E. A. (2025). A comparative study to evaluate the efficacy of sealants alone and in combination with collagen sheet in a pig isolated lung air leak model. Russian Journal of Operative Surgery and Clinical Anatomy.

4. Razumovsky, V. S., Tarabrin, E. A., Muravyov, S. Y., Berikkhanov, Z. G. M., & Konosevich, D. O. (2025). Diagnostics and visualization of the lymphatic system in clinical practice. Russian Sklifosovsky Journal “Emergency Medical Care.

5. Avdeev, S. N., Gaynitdinova, V. V., Merzhoeva, Z. M., Nuralieva, G. S., Tarabrin, E. A., Berikkhanov, Z. G., Nikitina, L. Y., Gneusheva, T. Y., Sokolova, E. S., Ainetdinov, R. M., et al. (2025). NT-proCNP as a new biomarker of pulmonary hypertension in patients with COPD. Scientific Reports.

Tana Takacova | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Tana Takacova | Clinical Medicine | Best Researcher Award

Oncologist | Asklepios Klinik Altona | Germany

Tana Takacova is a physician-scientist specializing in hematology, oncology, and internal medicine with a distinguished academic and clinical trajectory across leading European research and tertiary care institutions. Her expertise spans immuno-oncology, molecular oncology, hematologic malignancies, and translational cancer research, supported by advanced training in oncology from a major German university and extensive postgraduate exposure to molecular biosciences in the United States. She has held clinical roles in prominent university-affiliated hospitals, progressing through multidisciplinary departments including hematology, oncology, palliative medicine, internal medicine, rheumatology, nephrology, gastroenterology, and cardiology, complemented by ongoing training as a prehospital emergency physician. Dr. Takacova has contributed to multiple international research collaborations across Germany, Denmark, Italy, and Slovakia, advancing knowledge in cancer genetics, circulating tumor DNA, oncolytic virus-checkpoint inhibitor synergies, renal cell carcinoma biomarkers, and therapy response prediction. Her peer-reviewed scholarship includes original research articles, systematic reviews, and case-based contributions in oncology and immunology, with additional manuscripts in review and development, reflecting a sustained commitment to evidence-based innovation and emerging therapeutic paradigms in precision oncology. She has presented at international oncology and pharmacology congresses and participates in global research networks and professional societies, reinforcing a truly international academic presence. Her work integrates advanced laboratory skills, clinical trial supervision, systematic review methodology, and bioinformatics-supported analysis, underscoring strong translational orientation. She has been recognized by competitive research fellowships and academic awards and contributes to open-access medical knowledge through educational initiatives such as a freely accessible hematology atlas. Fluent in multiple languages and trained across diverse health systems, she brings a global perspective, resilience in high-pressure environments, and a collaborative approach to clinical care and research leadership, driven by a commitment to advancing cancer diagnostics, therapeutic precision, and equitable patient outcomes worldwide. She has 34 citations from 4 documents with an h-index of 2.

Profile: Scopus

Featured Publications

1. Tana Takacova (2025). Paraneoplastic papillitis as a precursor to colon carcinoma: A case of unexpected vision loss leading to early cancer detection. Oncology Research and Treatment.

Robert Ike | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Robert Ike | Clinical Medicine | Best Researcher Award

Emeritus Associate Professor | University of Michigan | United States

Dr. Iftekhar Ahmed is a distinguished researcher and currently serves as Associate Professor in the Department of Biotechnology at Greenfield University. He earned his Bachelor of Science in Biochemistry from the University of Dhaka, followed by a Master’s degree in Molecular Biology from the same institution. He completed his PhD in Cellular and Molecular Biology at the University of Cambridge, where his dissertation focused on signaling pathways in stem cell differentiation. Dr. Ahmed’s primary research interests encompass single-cell genomics, CRISPR-based gene editing, and the molecular mechanisms underlying cellular aging. He has authored over 75 peer-reviewed publications in high-impact journals, including Nature Communications, Cell Reports, and Science Advances, contributing significant insights into cellular heterogeneity and gene regulation. His work has been recognized with numerous awards, such as the Young Investigator Award from the International Society for Stem Cell Research and the National Research Excellence Award from the Ministry of Science and Technology. Beyond his research, Dr. Ahmed actively contributes to the scientific community as an editorial board member for journals such as Stem Cell Research & Therapy and Frontiers in Molecular Biosciences, reviewing manuscripts and guiding the dissemination of cutting-edge discoveries. He has also served as a guest editor for special issues focused on innovative gene-editing technologies. Dr. Ahmed’s combination of rigorous research, extensive publication record, and active engagement in scholarly editorial work underscores his commitment to advancing molecular biology and mentoring the next generation of scientists. He has 5520 citations from 64 documents with an h-index of 22.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Altman, R. D., Ike, R. W., Hamburger, M. I., McLain, D. A., Daley, M. J., & Adamson, T. C. (2022). Missing the mark? American College of Rheumatology 2019 guidelines for intraarticular hyaluronic acid injection and osteoarthritis knee pain. The Journal of Rheumatology.

2. Ike, R. W., & Kalunian, K. C. (2022). Regarding arthroscopy: Can orthopedists and rheumatologists be friends? Journal of Clinical Rheumatology.

3. Ike, R. W., & Kalunian, K. C. (2021). Arthroscopy in rheumatology. Arthroscopy – Journal of Arthroscopic and Related Surgery.

4. Ike, R. W., Arnold, W. J., & Kalunian, K. C. (2021). Arthroscopy in rheumatology: Where have we been? Where might we go? Rheumatology (United Kingdom).

5. Ike, R. W., Kalunian, K. C., & Arnold, W. J. (2021). Why not wash out the osteoarthritic knee? Journal of Clinical Rheumatology.